The B16-F10 melanoma model is well established as a checkpoint refractory model in which PD-1 or PD-L1 blockade does not improve the overall survival alone (52, 53) or in combination with PMEL T cell–adoptive transfer (53, 54). The gene discussed is PDCD1; the disease is melanoma.